HYDROXYCHLOROQUINE SULFATE — all Canadian products
12 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is HYDROXYCHLOROQUINE SULFATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02506696 | ACH-HYDROXYCHLOROQUINE SULFATE | ACCORD HEALTHCARE INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Approved | |
| 02510863 | AG-HYDROXYCHLOROQUINE | ANGITA PHARMA INC. | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Approved | |
| 02246691 | APO-HYDROXYQUINE | APOTEX INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02519348 | HYDROXYCHLOROQUINE | SANIS HEALTH INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02491427 | JAMP HYDROXYCHLOROQUINE SULFATE | JAMP PHARMA CORPORATION | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02424991 | MINT-HYDROXYCHLOROQUINE | MINT PHARMACEUTICALS INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02511886 | NRA-HYDROXYCHLOROQUINE | NORA PHARMA INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02017709 | PLAQUENIL | SANOFI-AVENTIS CANADA INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Marketed | |
| 02252600 | MYLAN-HYDROXYCHLOROQUINE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Cancelled Post Market | |
| 02335816 | NU-HYDROXYQUINE | NU-PHARM INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Cancelled (Unreturned Annual) | |
| 02247113 | PMS-HYDROXYCHLOROQUINE | PHARMASCIENCE INC | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Cancelled Pre Market | |
| 02311011 | PRO-HYDROXYQUINE - 200 | PRO DOC LIMITEE | Tablet | Oral | HYDROXYCHLOROQUINE SULFATE 200 MG | Cancelled Post Market |
Browse other molecules: